US Physical Therapy Inc
F:UPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
US Physical Therapy Inc
F:UPH
|
US |
|
Pennon Group PLC
F:3PN0
|
UK |
|
P
|
Pantheon Infrastructure PLC
LSE:PINT
|
UK |
|
Mitsui Fudosan Co Ltd
OTC:MTSFF
|
JP |
|
M
|
Mitsubishi Chemical Group Corp
DUS:M3C
|
JP |
|
M
|
Mitsui & Co Ltd
DUS:MTS1
|
JP |
|
E
|
Edwards Lifesciences Corp
F:EWL
|
US |
US Physical Therapy Inc
US Physical Therapy owns and manages outpatient physical therapy clinics and related rehabilitation centers. Its therapists treat people recovering from injuries, surgery, or chronic pain, and it also serves employers with industrial injury prevention and on-site care programs. The company is paid for patient visits and therapy services, usually through insurance, Medicare, workers’ compensation, or direct payment. Its main customers are patients who need physical rehabilitation, plus employers and other organizations that want to reduce workplace injuries and speed employee recovery. The company also works with referring physicians and local medical groups, since many patients are sent to therapy after a doctor visit or procedure. That referral-based model is a key part of how its clinics stay busy. What makes the business different is that it is a clinic operator, not a drug maker or device company. It earns money from hands-on care delivered in local clinics and on customer sites, so its value comes from therapist expertise, patient relationships, and efficient clinic management. This gives it a steady role in the healthcare system as a provider of routine rehabilitation services rather than specialized hospital care.
US Physical Therapy owns and manages outpatient physical therapy clinics and related rehabilitation centers. Its therapists treat people recovering from injuries, surgery, or chronic pain, and it also serves employers with industrial injury prevention and on-site care programs. The company is paid for patient visits and therapy services, usually through insurance, Medicare, workers’ compensation, or direct payment.
Its main customers are patients who need physical rehabilitation, plus employers and other organizations that want to reduce workplace injuries and speed employee recovery. The company also works with referring physicians and local medical groups, since many patients are sent to therapy after a doctor visit or procedure. That referral-based model is a key part of how its clinics stay busy.
What makes the business different is that it is a clinic operator, not a drug maker or device company. It earns money from hands-on care delivered in local clinics and on customer sites, so its value comes from therapist expertise, patient relationships, and efficient clinic management. This gives it a steady role in the healthcare system as a provider of routine rehabilitation services rather than specialized hospital care.
In line quarter: Management said Q1 came in almost exactly where they budgeted, despite weather disrupting more than 31,000 visits and pressuring margins.
Guidance reaffirmed: The company reaffirmed full-year 2026 adjusted EBITDA guidance of $102 million to $106 million and said the year’s key initiatives should ramp through 2026.
Growth drivers: Physical therapy revenue rose 7.2%, injury prevention revenue rose 11.8%, and same-store physical therapy revenue increased 2.5%.
Hospital ramp: The two hospital partnership initiatives are starting to roll out and should build sequentially through the year, with the full quarterly benefit not expected until late 2026.
Balance sheet: US Physical Therapy closed a larger $450 million credit facility at improved pricing, giving it more flexibility for acquisitions, partnerships, and capital returns.
Cash-based programs: Management is pushing cash-based offerings like laser, shockwave, and dry needling, saying partner interest is strong and traction is building.
